Unbiased Identification of Blood-based Biomarkers for Pulmonary Tuberculosis by Modeling and Mining Molecular Interaction Networks

EBioMedicine

Volumn 15, Issue , 2017, Pages 112-126

  Sambarey, Awanti ^a   Devaprasad, Abhinandan ^a   Mohan, Abhilash ^a   Ahmed, Asma ^a   Nayak, Soumya ^a   Swaminathan, Soumya ^b   D'Souza, George ^c   Jesuraj, Anto ^c   Dhar, Chirag ^c   Babu, Subash ^d   Vyakarnam, Annapurna ^a,e   Chandra, Nagasuma ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^c ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^d NATIONAL INSTITUTE OF FASHION TECHNOLOGY   (India)

^e GUY S HOSPITAL   (United Kingdom)

Author keywords

Biomarkers; Computational medicine; Diagnostics; Network biology; Tuberculosis

Indexed keywords

ADM PROTEIN; BIOLOGICAL MARKER; CAT EYE SYNDROME CHROMOSOME REGION CANDIDATE 6 PROTEIN; FC FRAGMENT OF IGE RECEPTOR IA; FLUOROURACIL; HEXOKINASE; HUMAN LEUKOTRIENE B4 OMEGA HYDROXYLASE; IFFI44L PROTEIN; ONCOSTATIN M; PEPTIDES AND PROTEINS; PROTEIN BCL 6; RAB13 PROTEIN; RB BINDING PROTEIN 8; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SMARCD3 PROTEIN; TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 10; TROPONIN I; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE LIBRARY; GENE SEQUENCE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; TRANSCRIPTOMICS; TUBERCULIN TEST; ADOLESCENT; BIOLOGICAL MODEL; BIOLOGY; BLOOD; CASE CONTROL STUDY; CLUSTER ANALYSIS; DATA MINING; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PROCEDURES; PROGNOSIS; PROTEIN ANALYSIS; REPRODUCIBILITY; SIGNAL TRANSDUCTION; TUBERCULOSIS, PULMONARY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; COINFECTION; COMPUTATIONAL BIOLOGY; DATA MINING; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; PROGNOSIS; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 85008645140     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.12.009     Document Type: Article

References (51)

1. Azad, A.K., Sadee, W., Schlesinger, L.S., Innate immune gene polymorphisms in tuberculosis. Infect. Immun. 80:10 (2012), 3343–3359.
2. Berry, M.P., Graham, C.M., McNab, F.W., Xu, Z., Bloch, S.A., Oni, T., Wilkinson, K.A., Banchereau, R., Skinner, J., Wilkinson, R.J., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466:7309 (2010), 973–977.
3. Blankley, S., Berry, M.P.R., Graham, C.M., Bloom, C.I., Lipman, M., O'Garra, A., The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis. Philos. Trans. R. Soc. Lond. B Biol. Sci., 369(1645), 2014, 20130427.
4. Bloom, C.I., Graham, C.M., Berry, M.P., Rozakeas, F., Redford, P.S., Wang, Y., Xu, Z., Wilkinson, K.A., Wilkinson, R.J., Kendrick, Y., et al. Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLoS One, 8(8), 2013, e70630.
5. Chatr-Aryamontri, A., Breitkreutz, B.-J., Oughtred, R., Boucher, L., Heinicke, S., Chen, D., Stark, C., Breitkreutz, A., Kolas, N., O'Donnell, L., The BioGRID interaction database: 2015 update. Nucleic Acids Res. 43:D1 (2015), D470–D478.
6. Chen, E.Y., Tan, C.M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G.V., Clark, N.R., Ma'ayan, A., Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinf., 14, 2013, 128.
7. Cliff, J.M., Kaufmann, S.H., McShane, H., van Helden, P., O'Garra, A., The human immune response to tuberculosis and its treatment: a view from the blood. Immunol. Rev. 264:1 (2015), 88–102.
8. Cooper, A.M., Cell mediated immune responses in tuberculosis. Annu. Rev. Immunol. 27 (2009), 393–422.
9. Dietzold, J., Gopalakrishnan, A., Salgame, P., Duality of lipid mediators in host response against Mycobacterium tuberculosis: good cop, bad cop. F1000prime Reports, 2015, 7.
10. Fazekas, D., Koltai, M., Türei, D., Módos, D., Pálfy, M., Dúl, Z., Zsákai, L., Szalay-Bekő, M., Lenti, K., Farkas, I.J., et al. SignaLink 2-a signaling pathway resource with multi-layered regulatory networks. BMC Syst. Biol., 7(1), 2013, 1.
11. Gui, X., Xiao, H., Diagnosis of tuberculosis pleurisy with adenosine deaminase (ADA): a systematic review and meta-analysis. Int. J. Clin. Exp. Med. 7:10 (2014), 3126–3135.
12. Haas, C.T., Roe, J.K., Pollara, G., Mehta, M., Noursadeghi, M., Diagnostic ‘omics’ for active tuberculosis. BMC Med. 14:1 (2016), 1–19.
13. Herrera, V., Perry, S., Parsonnet, J., Banaei, N., Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin. Infect. Dis. 52:8 (2011), 1031–1037.
14. Joosten, S.A., Fletcher, H.A., Ottenhoff, T.H.M., A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis. PLoS One, 8(9), 2013, e73230.
15. Kaforou, M., Wright, V.J., Oni, T., French, N., Anderson, S.T., Bangani, N., Banwell, C.M., Brent, A.J., Crampin, A.C., Dockrell, H.M., Detection of tuberculosis in HIV-infected and-uninfected African adults using whole blood RNA expression signatures: a case–control study. PLoS Med., 10(10), 2013, e1001538.
16. Khurana, E., Fu, Y., Chen, J., Gerstein, M., Interpretation of genomic variants using a unified biological network approach. PLoS Comput. Biol., 9(3), 2013, e1002886.
17. Krogan, N.J., Lippman, S., Agard, D.A., Ashworth, A., Ideker, T., The cancer cell map initiative: defining the hallmark networks of cancer. Mol. Cell 58:4 (2015), 690–698.
18. Maertzdorf, J., Ota, M., Repsilber, D., Mollenkopf, H.J., Weiner, J., Hill, P.C., Kaufmann, S.H., Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS One, 6(10), 2011, e26938.
19. Maertzdorf, J., Repsilber, D., Parida, S.K., Stanley, K., Roberts, T., Black, G., Walzl, G., Kaufmann, S.H., Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun. 12:1 (2011), 15–22.
20. Maertzdorf, J., Kaufmann, S.H.E., Weiner, J 3rd, Toward a unified biosignature for tuberculosis. Cold Spring Harb. Perspect. Med., 2014, a018531.
21. Maertzdorf, J., McEwen, G., Weiner, J. 3rd, Tian, S., Lader, E., Schriek, U., Mayanja-Kizza, H., Ota, M., Kenneth, J., Kaufmann, S.H., Concise gene signature for point-of-care classification of tuberculosis. EMBO Mol. Med. 8:2 (2016), 86–95.
22. Maertzdorf, J., Weiner, J 3rd, Mollenkopf, H.J., Bauer, T., Prasse, A., Muller-Quernheim, J., Kaufmann, S.H., Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc. Natl. Acad. Sci. U. S. A. 109:20 (2012), 7853–7858.
23. Maji, A., Misra, R., Mondal, A.K., Kumar, D., Bajaj, D., Singhal, A., Arora, G., Bhaduri, A., Sajid, A., Bhatia, S., Expression profiling of lymph nodes in tuberculosis patients reveal inflammatory milieu at site of infection. Sci. Rep., 5, 2015.
24. Mayer-Barber, K.D., Yan, B., Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses. Cell. Mol. Immunol., 2016.
25. Mazurek, G.H., Villarino, M.E., Guidelines for using the QuantiFERON®-TB test for diagnosing latent Mycobacterium tuberculosis infection. Morb. Mortal. Wkly Rep., 52, 2003, RR02.
26. Moguche, A.O., Shafiani, S., Clemons, C., Larson, R.P., Dinh, C., Higdon, L.E., Cambier, C.J., Sissons, J.R., Gallegos, A.M., Fink, P.J., ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis. J. Exp. Med. 212:5 (2015), 715–728.
27. Normand, R., Yanai, I., An introduction to high-throughput sequencing experiments: design and bioinformatics analysis. Deep Sequencing Data Analysis, 2013, 1–26.
28. O'Bryant, S.E., Mielke, M.M., Rissman, R.A., Lista, S., Vanderstichele, H., Zetterberg, H., Lewczuk, P., Posner, H., Hall, J., Johnson, L., et al. Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement., 2016.
29. Ottenhoff, T.H., Dass, R.H., Yang, N., Zhang, M.M., Wong, H.E., Sahiratmadja, E., Khor, C.C., Alisjahbana, B., van Crevel, R., Marzuki, S., et al. Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS One, 7(9), 2012, e45839.
30. Pai, M., Denkinger, C.M., Kik, S.V., Rangaka, M.X., Zwerling, A., Oxlade, O., Metcalfe, J.Z., Cattamanchi, A., Dowdy, D.W., Dheda, K., et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin. Microbiol. Rev. 27:1 (2014), 3–20.
31. Pawlowski, A., Jansson, M., Skold, M., Rottenberg, M.E., Kallenius, G., Tuberculosis and HIV co-infection. PLoS Pathog., 8(2), 2012, e1002464.
32. Petruccioli, E., Scriba, T.J., Petrone, L., Hatherill, M., Cirillo, D.M., Joosten, S.A., Ottenhoff, T.H., Denkinger, C.M., Goletti, D., Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur. Respir. J., 2016.
33. Py, B., Basmaciogullari, S., Bouchet, J., Zarka, M., Moura, I.C., Benhamou, M., Monteiro, R.C., Hocini, H., Madrid, R., Benichou, S., The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane. PLoS One, 4(3), 2009, e5006.
34. Ravn, P., Munk, M.E., Andersen, A.B., Lundgren, B., Lundgren, J.D., Nielsen, L.N., Kok-Jensen, A., Andersen, P., Weldingh, K., Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin. Diagn. Lab. Immunol. 12:4 (2005), 491–496.
35. Richeldi, L., An update on the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med. 174:7 (2006), 736–742.
36. Rienksma, R.A., Suarez-Diez, M., Mollenkopf, H.-J., Dolganov, G.M., Dorhoi, A., Schoolnik, G.K., dos Santos, V.A.P.M., Kaufmann, S.H.E., Schaap, P.J., Gengenbacher, M., Comprehensive insights into transcriptional adaptation of intracellular mycobacteria by microbe-enriched dual RNA sequencing. BMC Genomics, 16(1), 2015, 1.
37. Sambarey, A., Devaprasad, A., Baloni, P., Mishra, M., Mohan, A., Tyagi, P., Singh, A., Akshata, J.S., Sultana, R., Buggi, S., Chandra, N., Meta-analysis of host response networks identifies a common core in tuberculosis. NPJ Systems Biology and Applications, 2017 (in press).
38. Sambarey, A., Prashanthi, K., Chandra, N., Mining large-scale response networks reveals ‘topmost activities’ in Mycobacterium tuberculosis infection. Sci. Rep., 3, 2013.
39. Sambaturu, N., Mishra, M., Chandra, N., EpiTracer — an algorithm for identifying epicenters in condition-specific biological networks. BMC Genomics, 17(Suppl. 4), 2015, 543.
40. Shi, L., Salamon, H., Eugenin, E.A., Pine, R., Cooper, A., Gennaro, M.L., Infection with Mycobacterium tuberculosis induces the Warburg effect in mouse lungs. Sci. Rep., 5, 2016, 18176.
41. Su, G., Morris, J.H., Demchak, B., Bader, G.D., Biological network exploration with cytoscape 3. Curr. Protoc. Bioinformatics 47:8.13 (2014), 8.13.1–8.13.24.
42. Sultan, B., Benn, P., Mahungu, T., Young, M., Mercey, D., Morris-Jones, S., Miller, R.F., Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT. TB) in testing for latent tuberculosis infection among HIV-infected adults. Int. J. STD AIDS 24:10 (2010), 775–779.
43. Sweeney, T.E., Braviak, L., Tato, C.M., Khatri, P., Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir. Med. 4:3 (2016), 213–224.
44. Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K.P., STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res., 2014, gku1003.
45. Thye, T., Vannberg, F.O., Wong, S.H., Owusu-Dabo, E., Osei, I., Gyapong, J., Sirugo, G., Sisay-Joof, F., Enimil, A., Chinbuah, M.A., et al. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat. Genet. 42:9 (2010), 739–741.
46. Tobin, D.M., Roca, F.J., Ray, J.P., Ko, D.C., Ramakrishnan, L., An enzyme that inactivates the inflammatory mediator leukotriene B4 restricts mycobacterial infection. PLoS One, 8(7), 2013, e67828.
47. Tobin, D.M., Vary, J.C. Jr., Ray, J.P., Walsh, G.S., Dunstan, S.J., Bang, N.D., Hagge, D.A., Khadge, S., King, M.-C., Hawn, T.R., et al. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140:5 (2010), 717–730.
48. Wang, Z., Gerstein, M., Snyder, M., RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10:1 (2009), 57–63.
49. Weiner, J., Maertzdorf, J., Kaufmann, S.H.E., The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis. Ann. N. Y. Acad. Sci. 1283:1 (2013), 22–29.
50. World Health Organization, Global tuberculosis report. http://www.who.int/tb/publications/globalreport/en/, 2016 (Accessed 14 November 2016).
51. Zak, D.E., Penn-Nicholson, A., Scriba, T.J., Thompson, E., Suliman, S., Amon, L.M., Mahomed, H., Erasmus, M., Whatney, W., Hussey, G.D., et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet, 2016.